It’s Getting (More) Complicated: Emerging Challenges in Securities and Corporate Litigation
Cornerstone Research hosted Stanford University's Joseph Grundfest on emerging challenges in securities and corporate litigation.
Cornerstone Research Recognized in 2019 Merger Control Matter of the Year in the Americas
Global Competition Review cites Cornerstone Research’s work with the merging parties in AT&T/Time Warner.
Forbes Magazine Names Cornerstone Research to 2019 List of America’s Best Management Consulting Firms
Firm receives high marks across multiple areas of expertise.
In re BlackRock Mutual Funds Advisory Fee Litigation
Our client defeated a $1.5 billion suit in a trial over allegedly excessive advisory fees.
Expert Forum: Competition Issues in Platform Markets and the Digital Economy
This Cornerstone Research conference featured speakers from DG Competition, the UK Payment Systems Regulator, private practice, and academia discussing the evolving topic of platform markets.
EC’s Phase II Investigation of Essilor/Luxottica Merger
The Commission cleared the proposed merger unconditionally finding the parties would not gain market power to harm competition.
The Financial Conduct Authority’s First Competition Enforcement Decision
A Cornerstone Research expert was instructed by Eversheds Sutherland on behalf of its asset management client in the first case where the Financial Conduct Authority (FCA) has used its competition…
Dina Older Aguilar Honored as a Notable Woman Competition Professional
Ms. Older Aguilar was one of only four women economists to be recognized in the competition field in the Americas.
Negligence Lawsuit Against Healthcare Provider
This civil matter involving allegations of patient overtreatment settled.
2019 Who’s Who Legal: Forensic Accountants
Cornerstone Research consultants are selected for the 2019 list of leading forensic accountants in the legal investigations space.
Hsu et al. v. Puma Biotechnology Inc. et al.
Positive jury verdict in rare securities class action trial.
Alleged Kickbacks to Physicians by a Healthcare Company
After a DOJ investigation, the agency declined to intervene in the case.